Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy
dc.contributor.author | John, Scott | |
dc.contributor.author | Walwyn, David Richard | |
dc.contributor.author | DeFea, Kathryn | |
dc.contributor.author | Hales, Tim G. | |
dc.contributor.author | Walwyn, Wendy | |
dc.date.accessioned | 2024-06-21T09:28:24Z | |
dc.date.available | 2024-06-21T09:28:24Z | |
dc.date.issued | 2023-07-14 | |
dc.description.abstract | No abstract available. | en_US |
dc.description.department | Graduate School of Technology Management (GSTM) | en_US |
dc.description.librarian | am2024 | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.uri | http://www.frontiersin.org/Pharmacology | en_US |
dc.identifier.citation | John, S., Walwyn, D.R., DeFea, K., Hales, T.G. & Walwyn, W. (2023), Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy. Frontiers in Pharmacology 14:1251958. DOI: 10.3389/fphar.2023.1251958. | en_US |
dc.identifier.issn | 1663-9812 (online) | |
dc.identifier.other | 10.3389/fphar.2023.1251958 | |
dc.identifier.uri | http://hdl.handle.net/2263/96591 | |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media | en_US |
dc.rights | © 2023 John, Walwyn, DeFea, Hales and Walwyn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). | en_US |
dc.subject | Opioid use disorder | en_US |
dc.subject | Substance use disorder | en_US |
dc.subject | Opioid use disorder treatment | en_US |
dc.subject | Substance use disorder treatment | en_US |
dc.subject | COVID-19 pandemic | en_US |
dc.subject | Coronavirus disease 2019 (COVID-19) | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.subject | Editorial | en_US |
dc.title | Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy | en_US |
dc.type | Article | en_US |